Bortezomib
NDC 70511-162, bortezomib, injection, from MAIA Pharmaceuticals, Inc..
- Product NDC
- 70511-162
- Status
- Listed
- Labeler
- MAIA Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215331
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70511-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB2.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70511-162-02 | 70511016202 | 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-162-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c40e6a28-d577-43d4-bca6-bef28da1d580
Use it
Look up 70511-162 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70511-162 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70511-162. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.